Management of Drug-Induced Interstitial Lung Disease - Episode 13
Rate of ILD and Monitoring Parameters
Tiffany A. Traina, MD, Memorial Sloan Kettering Cancer Center, Hope S. Rugo, MD, FASCO, UCSF Helen Diller Family Comprehensive Cancer Center, Axel Grothey, MD, West Cancer Center, University of Tennessee, Jarushka Naidoo, MBBCh, Sidney Kimmel Cancer Center, Johns Hopkins, Tanios Bekaii-Saab, MD, FACP, Mayo Clinic
